Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Toggle navigation
Contact Us
Subscribe
Promote Your Event
e-Edition
Privacy Policy
Terms of Service
Local Weather
Home Delivery
Submission Forms
News
Local News
The Leader
Heartland News
Sports
Entertainment
Local Events
Multimedia
Photo Galleries
Videos
Obituaries
Classifieds
Real Estate
Property for Rent
Cars & Vehicles
Jobs
Items for Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place an ad
Legals
Best of 2022
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
145.14
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EST, Feb 7, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
115
Open
145.14
Bid (Size)
143.82 (1)
Ask (Size)
145.71 (1)
Prev. Close
145.14
Today's Range
145.14 - 145.14
52wk Range
134.09 - 175.91
Shares Outstanding
N/A
Dividend Yield
3.58%
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
3 High-Yield Dividend Stocks to Buy Now for a Lifetime of Passive Income
February 07, 2023
These highly reliable healthcare stocks offer investors above-average dividend yields right now.
Via
The Motley Fool
NeurAxis IPO Sets Stage To Take On Irritable Bowel Syndrome With A Non-Surgical Solution
February 06, 2023
As NeurAxis gears up for its upcoming IPO, we take a deep dive into the company to see if it's worth adding to your investment portfolio.
Via
Talk Markets
Performance
YTD
-10.62%
-10.62%
1 Month
-10.22%
-10.22%
3 Month
-2.28%
-2.28%
6 Month
+3.49%
+3.49%
1 Year
+1.83%
+1.83%
More News
Read More
On Tap: Earnings from Disney, Powell Speech as Market Digests Blockbuster Jobs Data
February 06, 2023
Via
Benzinga
Five Best And Worst Performing Healthcare Stocks In January 2023
February 05, 2023
Via
Talk Markets
2 Stocks Down More Than 6% to Buy Right Now
February 04, 2023
Via
The Motley Fool
2 Steady Stocks to Buy in a Recession
February 03, 2023
Via
The Motley Fool
2 of the Best Dividend Stocks to Own in 2023
January 28, 2023
Via
The Motley Fool
Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years
January 25, 2023
Via
Benzinga
3 Unstoppable Dividend Stocks to Buy in February
February 04, 2023
Via
The Motley Fool
If You Want Tons of Passive Income in the Future , Buy These 2 Stocks
February 03, 2023
Via
The Motley Fool
Here's What's Next For Biohaven After Its $12 Billion Pfizer Buyout, According To CEO Vlad Coric
February 02, 2023
Via
Investor's Business Daily
The 3 Most Undervalued Penny Stocks to Buy in February 2023
February 02, 2023
Via
InvestorPlace
2 Surefire Stocks to Buy in 2023 and Hold for at Least the Next Decade
February 02, 2023
Via
The Motley Fool
3 Ultra-Profitable Businesses to Invest in for the Long Haul
February 02, 2023
Via
The Motley Fool
Amgen Records Slight Fall In Quarterly Earnings; Lower COVID-19 Manufacturing Pacts Impact Bottomline
February 01, 2023
Via
Benzinga
3 Juicy Dividend Stocks in Warren Buffett's Secret Portfolio to Buy in February
February 01, 2023
Via
The Motley Fool
AbbVie's Two-Decade Humira Monopoly Ends With Amgen's 55% Discounted Knockoff
January 31, 2023
Via
Investor's Business Daily
These 3 Healthcare Stocks With Over 3% Dividend Yields Are Recommended By Benzinga's Most Accurate Analysts
January 31, 2023
Via
Benzinga
Sector Shift Stalls Healthcare Stocks But Biotech Shows Gains In January
January 30, 2023
Via
Talk Markets
Down 14.5%, Is Pfizer Stock a Screaming Buy?
January 30, 2023
Via
The Motley Fool
S&P Global, AbbVie, And This Big 3 Automaker On CNBC's 'Final Trades'
January 30, 2023
Via
Benzinga
7 Dividend Stocks to Buy Now or You’ll Be Kicking Yourself Later
January 28, 2023
Via
InvestorPlace
5 Cheapest Health Care Stocks You Should Think About
January 27, 2023
Via
Benzinga
3 Gene Editing Stocks to Buy Now OR You’ll Be Kicking Yourself Later
January 25, 2023
Via
InvestorPlace
3 Reasons to Buy AbbVie and 2 Reasons Not to Buy
January 25, 2023
Via
The Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.